Nodular regenerative hyperplasia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
It can be a complication of [[azathioprine]] therapy.<ref name="pmid15980758">{{cite journal |author=Daniel F, Cadranel JF, Seksik P, ''et al'' |title=Azathioprine induced nodular regenerative hyperplasia in IBD patients |journal=Gastroenterol. Clin. Biol. |volume=29 |issue=5 |pages=600–3 |year=2005 |month=May |pmid=15980758 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/MDOI-GCB-05-2005-29-5-0399-8320-101019-200514077}}</ref><ref name="pmid17504943">{{cite journal |author=Vernier-Massouille G, Cosnes J, Lemann M, ''et al'' |title=Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine |journal=Gut |volume=56 |issue=10 |pages=1404–9 |year=2007 |month=October |pmid=17504943 |doi=10.1136/gut.2006.114363 |url=http://gut.bmj.com/cgi/pmidlookup?view=long&pmid=17504943}}</ref> | It can be a complication of [[azathioprine]] therapy.<ref name="pmid15980758">{{cite journal |author=Daniel F, Cadranel JF, Seksik P, ''et al'' |title=Azathioprine induced nodular regenerative hyperplasia in IBD patients |journal=Gastroenterol. Clin. Biol. |volume=29 |issue=5 |pages=600–3 |year=2005 |month=May |pmid=15980758 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/MDOI-GCB-05-2005-29-5-0399-8320-101019-200514077}}</ref><ref name="pmid17504943">{{cite journal |author=Vernier-Massouille G, Cosnes J, Lemann M, ''et al'' |title=Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine |journal=Gut |volume=56 |issue=10 |pages=1404–9 |year=2007 |month=October |pmid=17504943 |doi=10.1136/gut.2006.114363 |url=http://gut.bmj.com/cgi/pmidlookup?view=long&pmid=17504943}}</ref> | ||
==Causes== | |||
*Drug Side Effect: | |||
**[[Ado-trastuzumab emtansine]] | |||
==References== | ==References== | ||
Revision as of 14:19, 20 February 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Nodular regenerative hyperplasia is a form of liver hyperplasia associated with portal hypertension.[1]
It can be a complication of azathioprine therapy.[2][3]
Causes
- Drug Side Effect:
References
- ↑ Shelly D, Tevatia MS, Praharaj AK, Mehta A, Harish S, Baskaran V (2008). "Nodular regenerative hyperplasia of liver". Indian J Pathol Microbiol. 51 (1): 78–80. PMID 18417867.
- ↑ Daniel F, Cadranel JF, Seksik P; et al. (2005). "Azathioprine induced nodular regenerative hyperplasia in IBD patients". Gastroenterol. Clin. Biol. 29 (5): 600–3. PMID 15980758. Unknown parameter
|month=ignored (help) - ↑ Vernier-Massouille G, Cosnes J, Lemann M; et al. (2007). "Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine". Gut. 56 (10): 1404–9. doi:10.1136/gut.2006.114363. PMID 17504943. Unknown parameter
|month=ignored (help)